These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31619256)

  • 21. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
    Park A; Lee Y; Kim MS; Kang YJ; Park YJ; Jung H; Kim TD; Lee HG; Choi I; Yoon SR
    Front Immunol; 2018; 9():1859. PubMed ID: 30140269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression.
    Hu J; Liu J; Chen A; Lyu J; Ai G; Zeng Q; Sun Y; Chen C; Wang J; Qiu J; Wu Y; Cheng J; Shi X; Song L
    Oncotarget; 2016 Nov; 7(44):72250-72262. PubMed ID: 27750218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
    Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of irradiation-induced intercellular adhesion molecule-1 expression on natural killer cell-mediated cytotoxicity toward human cancer cells.
    Jeong JU; Uong TNT; Chung WK; Nam TK; Ahn SJ; Song JY; Kim SK; Shin DJ; Cho E; Kim KW; Cho D; Yoon MS
    Cytotherapy; 2018 May; 20(5):715-727. PubMed ID: 29572116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.
    Moriwaki K; Noda K; Furukawa Y; Ohshima K; Uchiyama A; Nakagawa T; Taniguchi N; Daigo Y; Nakamura Y; Hayashi N; Miyoshi E
    Gastroenterology; 2009 Jul; 137(1):188-98, 198.e1-2. PubMed ID: 19361506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer group 2D receptor and its ligands in cancer immune escape.
    Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
    Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer.
    Wang H; Liu B; Wang J; Li J; Gong Y; Li S; Wang C; Cui B; Xue X; Yang M; Fan W; Kang Z; Kamran M; Xu J; Tian P; Luo Y; Hou Z; Dong L; Ren Y; Li M; Wen Q; Cheng W; Xu L; Wang L; Liu Q
    Cell Physiol Biochem; 2017; 44(3):1051-1063. PubMed ID: 29179207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NANOG gene expression is regulated by the ETS transcription factor ETV4 in human embryonic carcinoma NCCIT cells.
    Park SW; Do HJ; Choi W; Song H; Chung HJ; Kim JH
    Biochem Biophys Res Commun; 2017 Jun; 487(3):532-538. PubMed ID: 28412366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
    J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.
    Gao S; Wang P; Hua Y; Xi H; Meng Z; Liu T; Chen Z; Liu L
    Oncotarget; 2016 Jan; 7(2):1608-18. PubMed ID: 26636540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
    Zhang X; Rao A; Sette P; Deibert C; Pomerantz A; Kim WJ; Kohanbash G; Chang Y; Park Y; Engh J; Choi J; Chan T; Okada H; Lotze M; Grandi P; Amankulor N
    Neuro Oncol; 2016 Oct; 18(10):1402-12. PubMed ID: 27116977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma.
    Jiang L; Shan J; Shen J; Wang Y; Yan P; Liu L; Zhao W; Xu Y; Zhu W; Su L; Chen J; Cheng F; Yao H; Xu H; Qian C; Liang Z
    Oncotarget; 2016 Jun; 7(24):36814-36828. PubMed ID: 27167111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
    Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
    Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forced expression of Nanog with mRNA synthesized in vitro to evaluate the malignancy of HeLa cells through acquiring cancer stem cell phenotypes.
    Ding Y; Yu AQ; Wang XL; Guo XR; Yuan YH; Li DS
    Oncol Rep; 2016 May; 35(5):2643-50. PubMed ID: 26936116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells.
    Wang B; Wang Q; Wang Z; Jiang J; Yu SC; Ping YF; Yang J; Xu SL; Ye XZ; Xu C; Yang L; Qian C; Wang JM; Cui YH; Zhang X; Bian XW
    Cancer Res; 2014 Oct; 74(20):5746-57. PubMed ID: 25164008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4.
    Lemos C; Hardt MS; Juneja M; Voss C; Förster S; Jerchow B; Haider W; Bläker H; Stein U
    Clin Cancer Res; 2016 Jun; 22(11):2812-24. PubMed ID: 26758557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.
    Xu LJ; Ma Q; Zhu J; Li J; Xue BX; Gao J; Sun CY; Zang YC; Zhou YB; Yang DR; Shan YX
    Mol Med Rep; 2018 Jun; 17(6):8111-8120. PubMed ID: 29693186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
    Qin S; Li Y; Cao X; Du J; Huang X
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.